sub banner

LambdaVision, Inc. is commercializing a retinal implant to restore vision for the millions of patients suffering from retinitis pigmentosa (RP) and age-related macular degeneration (AMD).

Both RP and AMD lead to the loss of photoreceptor cells, and the retinal implant developed by LambdaVision is inserted behind the retina to replace the function of these damaged cells.


Connecticut Magazine: Farmington Company's Quest to Cure Blindness Set to Launch Into Orbit
December 27, 2017
The January Edition of Connecticut Magazine features LambdaVision's efforts in treating retinal degenerative diseases and our upcoming experiments aboard the International Space Station.

Hartford Courant: At UConn, A Cure for Blindness in Sight
November 6, 2017
LambdaVision is featured in an article published in the Hartford Courant, which discusses the protein-based retinal implant technology and the founding team's efforts towards commercialization.

LambdaVision CEO Wins $10K at The Refinery's Pitch Competition
October 20, 2017
LambdaVision CEO, Dr. Nicole Wagner, won 1st prize and $10K at The Refinery's Fueling the Growth Pitch Competition.

LambdaVision Awarded $500K from Connecticut Innovations
October 18, 2017
LambdaVision was awarded $500,000 in Series A Equity from Connecticut Innovations through the Connecticut Bioscience Innovation Fund (CBIF). Read more about the award in this press release and in the article featured in the Hartford Business Journal.

Boston VisionWalk 2017
October 5, 2017
Join us at the Boston VisionWalk on Saturday, October 28th and consider donating to Foundation Fighting Blindness to support vital vision research!

Inside UConn TIP: LambdaVision Podcast
September 12, 2017
The first episode of "Inside UConn TIP", a podcast series about the UConn startup community, features a discussion on LambdaVision's protein-based retinal prosthetic. The podcast is available on Soundcloud and iTunes now.

Report on the Protein-Based Retinal Implant Published in Int. J. High Speed Electron. Syst.
June 28, 2017
In 2015, Dr. André Fernandes joined the LambdaVision team and the research group of Dr. Robert Birge (UConn) as a guest post-doctoral researcher through the Lief Eriksson mobility program via the Research Council of Norway. Dr. Fernandes joined us from the research group of Dr. Erik Johannessen (University College of Southeast Norway), and the collaboration also implemented a novel technology developed by Dr. Philipp Häfliger (University of Oslo). In a recently published article in the International Journal of High Speed Electronics and Systems, we report on the initial results from this ongoing international collaboration: "Pixel Properties of a Protein-Based Retinal Implant Using a Microfabricated PIxel Array".

sub banner

Home | About | Indications | Product | News | Resources
 © 2017 LambdaVision, Inc. All Rights Reserved. Website by J. A. Greco.